This inventor holds 2 USPTO granted patents. Top assignee: Zeneca Limited. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: Zbigniew Stanely Matusiak: Innovator in Pharmaceutical Chemistry
Introduction
Zbigniew Stanely Matusiak is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of farnesyl transferase inhibitors. His work is crucial in the ongoing fight against cancer.
Latest Patents
Matusiak holds 2 patents related to 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors. These patents describe pharmaceutical compositions that comprise an inhibitor of ras farnesylation, with specific formulas and variations defined in the specifications. The compounds he has developed are particularly useful in cancer therapy, showcasing his commitment to advancing medical science.
Career Highlights
Matusiak is currently associated with Zeneca Limited, a company known for its innovative approaches in pharmaceuticals. His work at Zeneca has allowed him to focus on developing new therapeutic options that can significantly impact patient care.
Collaborations
Throughout his career, Matusiak has collaborated with esteemed colleagues such as David Huw Davies and Francis Thomas Boyle. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Zbigniew Stanely Matusiak is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for innovative cancer therapies. His contributions are vital to the advancement of medical treatments and reflect his dedication to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile